342 related articles for article (PubMed ID: 29691737)
41. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
42. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
43. Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy.
Bogach J; Fenech D; Chu W; Ashamalla S; Ung Y; Taggar AS; Chan KKW; Earle CC; Wong CS
Cancer Treat Res Commun; 2021; 26():100287. PubMed ID: 33360327
[TBL] [Abstract][Full Text] [Related]
44. Surgical salvage therapy of anal cancer.
Bai YK; Cao WL; Gao JD; Liang J; Shao YF
World J Gastroenterol; 2004 Feb; 10(3):424-6. PubMed ID: 14760771
[TBL] [Abstract][Full Text] [Related]
45. Salvage abdominoperineal excisions in recurrent anal cancer--impact of different reconstruction techniques on outcome, morbidity, and complication rates.
Hannes S; Reinisch A; Bechstein WO; Habbe N
Int J Colorectal Dis; 2016 Mar; 31(3):653-9. PubMed ID: 26686872
[TBL] [Abstract][Full Text] [Related]
46. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
47. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
[TBL] [Abstract][Full Text] [Related]
48. Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China.
Lu Y; Wang X; Li P; Zhang T; Zhou J; Ren Y; Ding Y; Peng H; Wei Q; You K; Ong JJ; Fairley CK; Grulich AE; Huang M; Gao Y; Zou H
BMC Cancer; 2020 Jul; 20(1):679. PubMed ID: 32693779
[TBL] [Abstract][Full Text] [Related]
49. Malignancies of the anal canal: a multi-center retrospective analysis in South China population.
Sun P; Li YH; Wang W; Chen CQ; Wang LY
J BUON; 2014; 19(1):103-8. PubMed ID: 24659650
[TBL] [Abstract][Full Text] [Related]
50. Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors?
Stewart D; Yan Y; Kodner IJ; Birnbaum E; Fleshman J; Myerson R; Dietz D
J Gastrointest Surg; 2007 Dec; 11(12):1744-51. PubMed ID: 17846856
[TBL] [Abstract][Full Text] [Related]
51. Chemoradiotherapy for anal squamous cell carcinoma.
Houlihan OA; O'Neill BD
Surgeon; 2016 Aug; 14(4):202-12. PubMed ID: 27118047
[TBL] [Abstract][Full Text] [Related]
52. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
53. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
Chen YW; Yen SH; Chen SY; Huang PI; Shiau CY; Liu YM; Lin JK; Wang LW
J Surg Oncol; 2007 Oct; 96(5):374-80. PubMed ID: 17492635
[TBL] [Abstract][Full Text] [Related]
54. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
55. Patterns of recurrence in anal canal carcinoma.
Faynsod M; Vargas HI; Tolmos J; Udani VM; Dave S; Arnell T; Stabile BE; Stamos MJ
Arch Surg; 2000 Sep; 135(9):1090-3; discussion 1094-5. PubMed ID: 10982516
[TBL] [Abstract][Full Text] [Related]
56. Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal.
Wright JL; Gollub MJ; Weiser MR; Saltz LB; Wong WD; Paty PB; Temple LK; Guillem JG; Minsky BD; Goodman KA
Dis Colon Rectum; 2011 Sep; 54(9):1090-7. PubMed ID: 21825888
[TBL] [Abstract][Full Text] [Related]
57. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
[TBL] [Abstract][Full Text] [Related]
58. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
59. Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.
Ghareeb A; Paramasevon K; Mokool P; van der Voet H; Jha M
Ann R Coll Surg Engl; 2019 Mar; 101(3):168-175. PubMed ID: 30482037
[TBL] [Abstract][Full Text] [Related]
60. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
